D'Souza P
Clarivate Analytics, London, UK.
Drugs Today (Barc). 2018 Feb;54(2):169-175. doi: 10.1358/dot.2018.54.2.2792548.
During the fourth quarter of 2017, Cortellis Competitive Intelligence registered 1,107 new deals (excluding mergers & acquisitions) as part of its ongoing coverage of licensing activity in the life sciences sector compared to 1,043 in the third quarter and 1,035 in the fourth quarter of 2016.
在2017年第四季度,Cortellis竞争情报公司记录了1107笔新交易(不包括并购交易),这是其对生命科学领域许可活动持续跟踪报道的一部分,而在2016年第三季度这一数字为1043笔,2016年第四季度为1035笔。